PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $7,446 | -41.1% | 40,914 | -3.5% | 0.00% | – |
| Q3 2023 | $12,632 | -62.8% | 42,390 | +29.8% | 0.00% | – |
| Q4 2022 | $33,965 | -21.0% | 32,659 | -13.5% | 0.00% | – |
| Q3 2022 | $43,000 | -89.6% | 37,759 | -72.2% | 0.00% | -100.0% |
| Q1 2022 | $412,000 | -89.4% | 135,876 | -86.8% | 0.00% | -87.5% |
| Q4 2021 | $3,885,000 | -35.6% | 1,027,825 | -12.0% | 0.01% | -38.5% |
| Q3 2021 | $6,036,000 | +6533.0% | 1,167,548 | +3195.5% | 0.01% | – |
| Q1 2021 | $91,000 | -33.6% | 35,429 | -35.5% | 0.00% | – |
| Q4 2020 | $137,000 | +495.7% | 54,968 | +399.5% | 0.00% | – |
| Q3 2020 | $23,000 | -90.9% | 11,004 | -86.5% | 0.00% | -100.0% |
| Q2 2020 | $253,000 | +141.0% | 81,459 | +77.5% | 0.00% | 0.0% |
| Q1 2020 | $105,000 | -74.5% | 45,883 | -59.6% | 0.00% | 0.0% |
| Q4 2019 | $411,000 | +323.7% | 113,527 | +290.4% | 0.00% | – |
| Q1 2019 | $97,000 | -39.0% | 29,083 | -51.5% | 0.00% | -100.0% |
| Q4 2018 | $159,000 | +31.4% | 59,950 | +151.4% | 0.00% | – |
| Q2 2018 | $121,000 | -83.5% | 23,845 | -75.5% | 0.00% | -100.0% |
| Q4 2017 | $734,000 | – | 97,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |